Clinical Trial Update: Everolimus Stent in Patients With Coronary Artery Disease (CAD) [Phase 3]

View source ↗

Summary

This clinical trial update reports completion of a Phase 3 study evaluating an Everolimus-eluting stent for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Atherosclerosis

Drugs mentioned

• Everolimus-eluting stent (everolimus-eluting stent)

Snippet

Sponsor: San Giuseppe Moscati Hospital | Conditions: Coronary Artery Disease, Coronary Atherosclerosis | Phase 3 | Status: COMPLETED